Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease
替布利珠单抗（一种靶向 BAFF 和 IL-17A 的四价双特异性抗体）的研发，用于治疗自身免疫性疾病
期刊:MAbs
影响因子:5.6
doi:10.1080/19420862.2019.1624463
Robert J Benschop ,Chi-Kin Chow ,Yu Tian ,James Nelson ,Barbra Barmettler ,Shane Atwell ,David Clawson ,Qing Chai ,Bryan Jones ,Jon Fitchett ,Stacy Torgerson ,Yan Ji, Holly Bina ,Ningjie Hu ,Mahmoud Ghanem, Joseph Manetta ,Victor J Wroblewski ,Jirong Lu ,Barrett W Allan
IL-17
免疫/内分泌
自身免疫性疾病
IL-17A
BAF
